Michael Fuller, MD

  • 17 Citations
  • 2 h-Index
19992015
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael Fuller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Catatonia Medicine & Life Sciences
Mixed Function Oxygenases Medicine & Life Sciences
Cocaine Medicine & Life Sciences
Respiratory Insufficiency Medicine & Life Sciences
Dopamine Medicine & Life Sciences
Tracheostomy Medicine & Life Sciences
Antipsychotic Agents Medicine & Life Sciences
Muscle Rigidity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2015

  • 17 Citations
  • 2 h-Index
  • 2 Article
6 Citations (Scopus)

Evaluation of the dopamine β-hydroxylase (DβH) inhibitor nepicastat in participants who meet criteria for cocaine use disorder

De La Garza, R., Bubar, M. J., Carbone, C. L., Moeller, F. G., Newton, T. F., Anastasio, N., Harper, T. A., Ware, D. L., Fuller, M., Holstein, G. J., Jayroe, J. B., Bandak, S. I., Reiman, K. Z., Neale, A. C., Pickford, L. B. & Cunningham, K., Jun 3 2015, In : Progress in Neuro-Psychopharmacology and Biological Psychiatry. 59, p. 40-48 9 p.

Research output: Contribution to journalArticle

Mixed Function Oxygenases
Cocaine
Dopamine
nepicastat
Pharmacokinetics

Malignant catatonia-induced respiratory failure with response to ECT

Boyarsky, B. K., Fuller, M. & Early, T., 1999, In : Journal of ECT. 15, 3, p. 232-236 5 p.

Research output: Contribution to journalArticle

Catatonia
Respiratory Insufficiency
Tracheostomy
Antipsychotic Agents
Muscle Rigidity